- Home
- TNYA vs PRE Comparison
TNYA vs PRE Comparison
Compare TNYA & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNYA
- PRE
- Stock Information
- Founded
- TNYA 2016
- PRE 2014
- Country
- TNYA United States
- PRE Hong Kong
- Employees
- TNYA N/A
- PRE N/A
- Industry
- TNYA Medicinal Chemicals and Botanical Products
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- TNYA Health Care
- PRE Industrials
- Exchange
- TNYA Nasdaq
- PRE Nasdaq
- Market Cap
- TNYA 111.1M
- PRE 105.1M
- IPO Year
- TNYA 2021
- PRE N/A
- Fundamental
- Price
- TNYA $0.68
- PRE $7.74
- Analyst Decision
- TNYA Strong Buy
- PRE Buy
- Analyst Count
- TNYA 5
- PRE 1
- Target Price
- TNYA $8.60
- PRE $9.00
- AVG Volume (30 Days)
- TNYA 2.4M
- PRE 48.4K
- Earning Date
- TNYA 08-15-2025
- PRE 08-12-2025
- Dividend Yield
- TNYA N/A
- PRE N/A
- EPS Growth
- TNYA N/A
- PRE N/A
- EPS
- TNYA N/A
- PRE N/A
- Revenue
- TNYA N/A
- PRE $41,520,000.00
- Revenue This Year
- TNYA N/A
- PRE $198.17
- Revenue Next Year
- TNYA N/A
- PRE $59.73
- P/E Ratio
- TNYA N/A
- PRE N/A
- Revenue Growth
- TNYA N/A
- PRE 78.72
- 52 Week Low
- TNYA $0.36
- PRE $3.10
- 52 Week High
- TNYA $4.01
- PRE $11.99
- Technical
- Relative Strength Index (RSI)
- TNYA 43.13
- PRE 48.82
- Support Level
- TNYA $0.64
- PRE $7.78
- Resistance Level
- TNYA $0.80
- PRE $8.31
- Average True Range (ATR)
- TNYA 0.08
- PRE 0.42
- MACD
- TNYA -0.03
- PRE -0.03
- Stochastic Oscillator
- TNYA 4.48
- PRE 43.66
About TNYA Tenaya Therapeutics Inc.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.